Enclomiphene Citrate 7599-79-3 zaɓaɓɓen antagonist mai karɓar isrogen
Biya:T/T, L/C
Asalin samfur:China
Tashar Jirgin Ruwa:Beijing/Shanghai/Hangzhou
Ƙarfin samarwa:50kg/wata
Oda (MOQ):1 kg
Lokacin Jagora:3 Ranakun Aiki
Yanayin ajiya:Ajiye a wuri mai sanyi da bushewa, an rufe kuma a nisanta daga haske.
Kunshin kayan:kwalba, kwalba
Girman kunshin:1kg / vial, 5kg / vial, 10kg / vial, 25kg / ganga
Bayanin aminci:Ba kayan haɗari ba
Gabatarwa
An yi amfani da Enclomiphene da farko a matsayin magani ga maza tare da ƙananan ƙananan testosterone sakamakon sakamakon hypogonadotropic hypogonadism na biyu.A cikin hypogonadotropic hypogonadism na biyu, sakamakon ƙananan matakan testosterone ana danganta shi da rashin dacewa a cikin hypothalamic-pituitary-gonadadal axis.Sabanin haka, hypogonadism na farko yana haifar da lahani a cikin gwaje-gwajen da ke sa su kasa samar da adadin da ake bukata na testosterone.
Enclomiphene, wanda ke motsa samar da kwayoyin halitta na testosterone, ba a halin yanzu an san yana da mummunar tasiri na maganin maye gurbin testosterone na waje, irin su rage spermatogenesis ko rashin haihuwa.
Ƙayyadaddun (a daidaitaccen gida)
| Abubuwa | Ƙayyadaddun bayanai |
| Bayyanar | Fari mai ƙarfi |
| Asarar bushewa | ≤0.5% |
| Ragowa akan kunnawa | ≤0.1% |
| Karfe masu nauyi | ≤20ppm |
| Z isomers | ≤1.0%, ta HPLC |
| Jimlar ƙazanta | ≤1.0%, ta HPLC |
| Tsafta | ≥99.0% ta HPLC |
